Literature DB >> 19224202

Tigecycline and cyclosporine interaction-an interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine.

Nuggehally R Srinivas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19224202     DOI： 10.1007/s00228-009-0631-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

Authors:  Dennis A Hesselink; Reinier M van Hest; Ron A A Mathot; Fred Bonthuis; Willem Weimar; Ron W F de Bruin; Teun van Gelder
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

2.  High serum concentrations of cyclosporin related to administration of tigecycline.

Authors:  Anita N Stumpf; Christian Schmidt; Wolfgang Hiddemann; Armin Gerbitz
Journal:  Eur J Clin Pharmacol       Date:  2008-09-16       Impact factor: 2.953

3.  Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.

Authors:  Svitlana Igel; Siegfried Drescher; Thomas Mürdter; Ute Hofmann; Georg Heinkele; Heike Tegude; Hartmut Glaeser; Stefanie S Brenner; Andrew A Somogyi; Taher Omari; Christian Schäfer; Michel Eichelbaum; Martin F Fromm
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.

Authors:  Matthew Hoffmann; William DeMaio; Ronald A Jordan; Rasmy Talaat; Dawn Harper; John Speth; JoAnn Scatina
Journal:  Drug Metab Dispos       Date:  2007-05-30       Impact factor: 3.922

5.  CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.

Authors:  Séverine Crettol; Jean-Pierre Venetz; Massimiliano Fontana; John-David Aubert; Manuel Pascual; Chin B Eap
Journal:  Ther Drug Monit       Date:  2008-12       Impact factor: 3.681

6.  Absence of an interaction between tigecycline and digoxin in healthy men.

Authors:  James J Zimmerman; Dawn M Harper; Kyle Matschke; John L Speth; Donald G Raible; Richard J Fruncillo
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705
  6 in total
  1 in total

Review 1.  Pharmacokinetic Interaction of Rifampicin with Oral Versus Intravenous Anticancer Drugs: Challenges, Dilemmas and Paradoxical Effects Due to Multiple Mechanisms.

Authors:  Nuggehally R Srinivas
Journal:  Drugs R D       Date:  2016-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.